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Abstract
Herein, we develop a novel integrated strategy for the preparation of theranostic chitosan microcapsules by
encapsulating ion liquids (ILs) and Fe3O4 nanoparticles. The as-prepared chitosan/Fe3O4@IL microcapsules exhibit
not only significant heating efficacy in vitro under microwave (MW) irradiation but also obvious enhancement of
T2-weighted magnetic resonance (MR) imaging, besides the excellent biocompatibility in physiological
environments. The chitosan/Fe3O4@IL microcapsules show ideal temperature rise and therapeutic efficiency when
applied to microwave thermal therapy in vivo. Complete tumor elimination is realizing after MW irradiation at an
ultralow power density (1.8 W/cm2), while neither the MW group nor the chitosan microcapsule group has
significant influence on the tumor development. The applicability of the chitosan/Fe3O4@IL microcapsules as an
efficient contrast agent for MR imaging is proved in vivo. Moreover, the result of in vivo systematic toxicity shows
that chitosan/Fe3O4@IL microcapsules have no acute fatal toxicity. Our study presents an interesting type of
multifunctional platform developed by chitosan microcapsule promising for imaging-guided MW thermotherapy.
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Background
In recent years, microwave (MW) thermotherapy received
considerable attention due to many advantages including
the ability to achieve effective ablation of large tumors and
less heat sink effects, when compared with other cancer
therapies such as radiotherapy, chemotherapy, and surgery
[1–6]. For the clinical application of MW thermotherapy,
the main challenge is achieving a balance between
complete ablation of tumor tissue and minimum damage
to surrounding vital organs [7–11]. Nanomaterials have
emerged with the unique characteristics of localization of
the MW irradiation, which results in improving the
efficacy of MW hyperthermia and eliminating the limita-
tions. Carbon nanotubes and ferrite compounds have been
utilized as MW agents for MW thermotherapy [12–16],
whose heating efficacy was too low to use in vivo. Micro-
wave thermal therapy uses dielectric hysteresis to produce
heat. Heating of the tissue is based on agitation of water
molecules or ions under an electromagnetic field of
microwave frequency, rather than relying upon current
flow and resistive heating [17]. Two main mechanisms are
identified that trigger heating by microwave irradiation:
dipolar polarization mechanism and ionic conduction
mechanism [18–20]. The ionic conduction process repre-
sents a much higher heat-generating efficacy than the
dipolar polarization. Because of their ionic character and
high polarizability, room-temperature ionic liquids
(ILs) are extremely susceptible to microwave irradi-
ation [21–25]. As excellent absorbers, ILs show highly
efficient microwave heating, which provide superior
benefits for the application of tumor MW thermo-
therapy. In order to deliver the liquid-phase absorbers
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to the tumor site, encapsulation of the ILs with bio-
compatible microcapsules is one of the most promis-
ing resolutions. The microcapsules have a compact
shell structure, which can confine the oscillation of IL
leading to more serious friction and collision of mole-
cules and ions than the free IL. Thus efficient, rapid,
and selective heating occurs in the microcapsules.
Chitosan-based materials have sparked considerable
interest due to their good biocompatibility, biodegrad-
ability, and low production costs, all of which result
in their potential use in various biological and clinical
applications, including slimming, wound dressing, and
tissue engineering, especially those involving drug de-
livery [26–29]. Chitosan is composed of amido and
hydroxyl groups, which can be combined with poly-
mer and metal. Bhise et al. have designed sustained
release systems for the anionic drug naproxen using
chitosan as drug carrier matrix [30]. Sun et al. have
designed enoxaparin/chitosan nanoparticulate delivery
systems, providing very stable complexes that led to a
significantly improved drug uptake [31]. Guo et al.
have developed chitosan-coated hollow CuS nanopar-
ticles that assemble the cytosine-guanine oligodeoxy
nucleotides for photothermal therapy in a mouse
breast cancer model [32]. As compared to chitosan
particles with single modality, dual modalities with
both the therapeutic and imaging function offer great
potential to satisfy the increasing requirements in ad-
vanced tumor theranostic platform. In the platform,
the imaging modality can be used as contrast agents
to light up tumors and the therapeutic modality can
be used to destroy tumors. However, success on prep-
aration of chitosan microcapsules with payload of
MRI contrast agents and MW absorbers for imaging-
guided MW thermotherapy, to best of our knowledge,
has not yet been reported.
In this work, we have developed a facile strategy to
construct chitosan-based microcapsules as MW sus-
ceptible agent for tumor thermotherapy and contrast
agents for enhanced tumor MR imaging. The chito-
san/Fe3O4@IL microcapsules showed high MW con-
version efficiency in vitro MW heating experiment. In
vitro and in vivo toxicity results uncovered that these
microcapsules exhibited good biocompatibility. For
use in a mice model, the as-prepared microcapsules
showed dramatically enhanced MW thermotherapy
outcomes in vivo. It is the first report that using
chitosan/Fe3O4@IL microcapsules to kill the H22
tumor cells in mice with 100 % of tumor elimination.
In vivo imaging results demonstrated that these chito-
san/Fe3O4@ILmicrocapsules can achieve MR imaging-
guided MW thermotherapy. Our study highlights the




Ethylene glycol, ferric chloride hexahydrate (FeCl3·6H2O),
sodium acetate (NaAc), sodium citrate, acetate, glutaralde-
hyde, and chitosan (deacetylation degree = 80–95 %) were
purchased from Sinopharm Chemical Reagent Beijing Co.,
Ltd. Soybean oil was obtained from Beijing Guchuan Oil
Co. Span 80 was purchased from Institute of Tianjin Jinke
Fine Chemicals. 1-Butyl-3-methylimidazolium tetrafluo-
roborate (IL) was purchased from Shanghai Chengjie
Chemical Co., Ltd. Mercaptopropionic acid (MPA) was
obtained purchased from Alfa Aesar. Hematoxylin and
eosin (H&E stain) were obtained from Beijing Solarbio
Science and Technology (China). All chemicals were used
directly in our work without further purification.
Preparation of Fe3O4 NPs
The Fe3O4 NPs were prepared by a gradient solvother-
mal method. In a typical methods, 0.5 g FeCl3·6H2O was
dissolved in 5 mL ethylene glycol under stirring. Then,
0.15 g sodium citrate and 0.9 g NaAc were completely
dissolved in 10 mL ethylene glycol. And the above
solutions were mixed together under stirring and the pH
value was adjusted to 7. The solutions were translated
into a 50-mL Teflon lined stainless steel autoclave and
heated at 200 °C for 4 h. The black product was magnet-
ically collected and rinsed for four times with deionized
water and absolute ethanol, respectively, and then dried
at 50 °C for 24 h.
Preparation of Chitosan/Fe3O4@IL Microcapsules
Chitosan was completely dissolved in deionized water
with 3 % acetate, 0.02 g Fe3O4 NPs, and 8 % ILs at a
concentration of 0.045 g/mL and marked as water phase.
Fifty-milliliter soybean oil and 1.2 mL Span 80 were
mixed well and marked as oil phase. Ten-milliliter water
phase was slowly added into oil phase under stirring at
1200 r/min for 10 min to form water/oil emulsion
(Fig. 1a). Then, 1 mL 50 % glutaraldehyde was added
into the emulsion and heated at 60 °C for 60 min.
Finally, the microcapsules was collected by washing for
four times with deionized water and absolute ethanol,
respectively, followed by drying under 45 °C for 24 h.
Characterization
The morphology of as-prepared microcapsules was char-
acterized by scanning electron microscopy (SEM, S-4300,
Hitachi). Energy dispersive spectroscopy (EDS) was also
recorded by Hitachi S-4800 SEM. The surface functional
groups of the microcapsules were employed by Fourier
transform infrared spectrometry (FT-IR, Varian, Model
3100 Excalibur). Thermogravimetric analyses were per-
formed on a thermal analyzer (TG, ICES-001, Canadian)
in the range 25–800 °C with a heating rate of 10 °C/min in
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nitrogen atmosphere. Canon DS126231 digital camera
was recorded to take the tumor photographs. The UV/vis
absorption spectra were measured by a spectrophotom-
eter (JASCO V-570) at room temperature. Magnetic
measurements were investigated by a magnetometer
(Model PPMS-9).
In Vitro MW Heating Experiment
In the MW heating experiment, the as-prepared micro-
capsules were diluted to 1 mL by saline solution at a
concentration of 50 mg/mL. Then, the solution was
added into a 12-well plate with a thin bottom and
exposed to MW irradiation (1.8 W, 5 min, Beijing
Muheyu Electronics Co., LTD). The temperature of the
solution was detected with a fiber thermometers (Beijing
Dongfangruizhe Technology Co., LTD).
In Vitro Cytotoxicity
Fresh blood was collected from rabbit’s heart in a 10 mL
centrifuge tube, containing EDTA as the anticoagulant
(anticoagulant to blood ratio, 1:9, v/v). The whole blood
was centrifuged and washed with PBS for three times and
rediluted in PBS, to give a 2 % erythrocyte suspension.
0.5 mL microcapsules were added into glass tubes,
followed by the addition of 0.5 mL erythrocyte suspension
and kept at room temperature for 3 h. Subsequently, all
the samples were centrifuged at 10,000 rpm for 3 min.
The hemoglobin released from the erythrocytes in the
supernatant was determined at 570 nm by an ultraviolet
spectrophotometer. Distilled water and PBS solution were
used as a positive control (100 % lysis) and negative
control (0 % lysis), respectively. The content of hemolysis
rate (%) was determined as following formula: Hemolysis
rate (%) = (tested sample − negative control)/(positive
control − negative control) × 100. Triplicate samples were
repeated and the values were averaged.
The viability of cells were evaluated by 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenylte-trazolium bromide (MTT)
assays. Briefly, HepG2 cells were plated out at a concen-
tration of 4 × 104 cells/mL in 96-well plate and incubated
for 24 h at 37 °C with 5 % CO2. Then, different concen-
trations of microcapsules were added and incubated for
24 h. The control group was only incubated with HepG2
cells. MTT-phosphate saline-buffered solution (20 μL)
was then added and incubated for another 4 h. Finally,
the medium were removed and 150 mL dimethyl sulfox-
ide (DMSO) was added into each well. The absorbance
of the suspension was recorded by a scanning multiwall
Fig. 1 Chitosan synthesis and characterization. a A schematic illustration of microcapsules synthesis. b SEM images of chitosan, chitosan/Fe3O4,
and chitosan/Fe3O4@IL microcapsules. c FT-IR spectra of chitosan, chitosan/Fe3O4, and chitosan/Fe3O4@ILmicrocapsules. d Heating curves of
water, saline, and microcapsules under MW irradiation at a power density of 1.8 W/cm2 for 5 min
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spectrometer (Multiskan MK3 Thermo). The cell viabil-
ity (%) = (absorbance of experimental)/(absorbance of
control groups) × 100. All of the experiments were re-
peated five times for each group.
MW Heating Therapy
Experimentation with animals was governed by the Reg-
ulations of Experimental Animals of Beijing Authority
and approved by the Animal Ethics Committee of the
Peking University.
All ICR mice were obtained from Vital River Labora-
tory Animal Technology Co. Ltd., Beijing, and used
under the guidelines of the Institutional Animal Care.
An infrared thermal mapping apparatus (FLIR SC620)
with MW apparatus (Beijing Muheyu Electronics Co.,
LTD) were used to irradiate tumors in our experiment.
To develop H22 tumors, 107 H22 cells (0.1 mL) were
injected in the right axillary region of each mice. When
the size of the tumor reached to the 300 mm3, micro-
capsules were intratumorally injected at the concentra-
tion of 200 mg/kg. After the injection of microcapsules
for 1 hour, the tumor of each mouse was then irradiated
by the MW at the power density of 1.8 W/cm2 for
5 min. There were four groups of mice (control, MW,
chitosan/Fe3O4@IL +MW, chitosan/Fe3O4@IL) with five
mice for each group. The tumor sizes were measured by
a vernier caliper every 3 days and calculated as the
volume (V) = (length) × (width)2/2. After 17 days of
therapy, mice were sacrificed and the tumor tissues in
each group were weighed.
MR Imaging
T2-weighted MR imaging was obtained by using a 3.0 T
MR imaging instrument at room temperature (Signa
HDx; General Electric Medical Systems, USA). Dilu-
tions of microcapsules in water with different concen-
trations as a contrast agent were placed in 4.0 mL
eppendorf tubes for T2-weight MR imaging. Relativity
values of R2 were calculated through the curve fitting
of 1/T2 relaxation time versus the microcapsules
concentration. For in vivo MR imaging, 10-mg micro-
capsules were dispersed in 0.2 mL saline solution, then
chitosan/Fe3O4@IL microcapsules (200 mg/kg) were
intratumoral injected into the H22 tumor-bearing mice
and then taken for the T2-weighted MR imaging tests.
In Vivo Systematic Toxicity
A total of 20 healthy ICR mice were randomly divided
into three groups and injected subcutaneously in the
axillary region with 2000 mg/kg, 200 mg/kg, and without
treatment. Body weight was measured every 3 days by
electronic scale. After 17 days, mice were sacrificed for
performing a full necropsy. Organs (including liver,
spleen, lung, and kidney) were harvested, fixed in 10 %
formalin, embedded in paraffin, sectioned, stained with
hematoxylin and eosin (H&E) for histological exa-
mination using standard techniques, and observed by a
optical fluorescence microscope (Nikon Eclipse Ti-S,
CCD: Ri1).
Results and Discussion
Synthesis and Characterization of Microcapsules
The experimental route to fabricate chitosan/Fe3O4@IL
is presented in Fig. 1a. Starting from Fe3O4 NPs
Fig. 2 In vitro cytotoxicity. a Hemolyticrate of red blood cells
incubated with chitosan/Fe3O4@IL microcapsules at various
concentrations for 3 h, using PBS (−) and deionized water (+) as
negative and positive controls, respectively. Inset: the photo images
for direct observation of hemolysis for microcapsules. b Viabilities of
HepG2 cells incubated with chitosan/Fe3O4@IL microcapsules with
different concentrations for 24 h
Tang et al. Nanoscale Research Letters  (2016) 11:334 Page 4 of 8
prepared following a gradient solvothermal method, we
synthesized chitosan/Fe3O4@IL microcapsules by a sin-
gle coacervation route. The chitosan was cross-linked by
GA to form microcapsules. The morphological charac-
terizations of the chitosan, chitosan/Fe3O4, and chito-
san/Fe3O4@IL microcapsules were evaluated by SEM
(Fig. 1b). The microcapsules had similar metric, an
almost spherical shape. Shown in Additional file 1:
Figure S1 are the size distributions of microcapsules,
obtained by more than 200 samples in Fig. 1b. The
results indicated that the mean diameters of chitosan,
chitosan/Fe3O4, and chitosan/Fe3O4@IL microcapsules
were 4.95, 5.19, and 6.17 μm, respectively.
FT-IR analysis was carried out to confirm the possible
groups of chitosan microcapsules. As shown in Fig. 1c,
the characteristic absorption peaks at 1634, 1063, and
523 cm−1 were only observed in the chitosan/Fe3O4@IL
microcapsules, which are assigned to C–C stretching
vibrations of the imidazolium ring, asymmetric stretch-
ing vibrations of BF4
− and out-plane C–H bending vibra-
tions of imidazolium ring, respectively [33, 34]. These
distinct peaks suggest the presence of IL. The elemental
in microcapsules was carried out by EDS. Additional
file 1: Figure S2 shows the EDS spectra of chitosan
microcapsules, and only in chitosan/Fe3O4@IL mi-
crocapsules shows the existence of F element. More-
over, as presented in Additional file 1: Figure S3, after
the final thermal decomposition, the percentages of
weight of the chitosan, chitosan/Fe3O4, and chitosan/
Fe3O4@IL microcapsules were 16.49, 21.54, and 23.79 %,
respectively. The higher residual of content of the
chitosan/Fe3O4 and chitosan/Fe3O4@IL is certainly at-
tributable to the Fe3O4 and Fe3O4@IL in the micro-
capsules, respectively.
An important feature of IL was the MW-induced ther-
mal effect, which could be used for ablation of tumors.
The temperature elevation of microcapsules was investi-
gated under MW irradiation (1.8 W/cm−2) for 5 min.
Figure 1d shows the temperature of the aqueous disper-
sion of microcapsules as a function of irradiation time.
A rapid temperature increase of the chitosan/Fe3O4@IL
microcapsules when exposed to MW irradiation was
observed up to a high level (ΔT = 25.4 °C). However,
the water, saline, chitosan, and chitosan/Fe3O4groups
Fig. 3 In vivo MW therapy. a IR thermal imaging of tumor-bearing mice injected with none and chitosan/Fe3O4@IL microcapsules under MW
irradiation (1.8 W/cm2, 5 min). b The temperature changes on tumor of mice under different treatment in a. c Tumor growth curves of different
groups of tumor after various treatment. d Representative photos of mice bearing H22 tumor after different treatments indicated
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showed much less temperature change (ΔT = 7.8 °C,
ΔT = 17.4 °C, and ΔT = 17.5 °C, respectively), suggest-
ing that either saline or chitosan/Fe3O4 microcapsules had
less effect on the temperature elevation. MW could
directly excite ILs in chitosan microcapsules, which
led to significantly heating [35–39]. The temperature
elevation suggested that chitosan/Fe3O4@IL microcap-
sules could act as an efficient MW susceptible agent
for tumor ablation.
In Vitro Cell Experiments
Before using the synthesized chitosan/Fe3O4@IL micro-
capsules for biomedical application, we firstly evaluated
microcapsules in vitro toxicity to cells. Herein, hemolytic
behavior of red blood cells was carried out to evaluate its
biocompatibility, where deionized water and phosphate-
buffered saline were defined as positive and negative con-
trols, respectively. As presented in Fig. 2a, the hemolysis
rates of all the samples were below 5 %. The photographs
of hemolysis results show that almost no hemolysis of red
blood cells can be detected, suggesting that their good
blood compatibility (inset of Fig. 2a). Moreover, viabilities
of HepG 2 cells were measured after incubating with
chitosan/Fe3O4@IL at tested concentration. According to
the MTTassay, approximately >93 % of the cells remained
viable after being exposed to the microcapsules for 24 h.
Therefore, the hemolytic activity and low cytotoxicity
demonstrate that chitosan/Fe3O4@IL microcapsules
exhibits excellent biocompatibility and thus can serve as a
promising platform for cancer treatment.
In Vivo Cancer MW Therapy
Encouraged by the strong MW heating effect of chitosan/
Fe3O4@IL microcapsules presented in vitro experiment,
we then investigated in vivo cancer MW therapy using
chitosan/Fe3O4@IL microcapsules in a H22 tumor mouse
model. Female Institute for Cancer Research (ICR) mice
bearing H22 tumors were intratumorally injected with
chitosan/Fe3O4@IL microcapsules (200 mg/kg) and then
exposed to the MW irradiation at the power density of
1.8 W/cm2 for 5 min. Mice without treatment were used
as the control group. The temperature changes on tumor
were real-time monitored by an infrared thermal camera
and a fiber thermometer during MW irradiation. It was
uncovered that the temperature of the tumor injected with
chitosan/Fe3O4@IL microcapsules rapidly increased to
about 51.2 °C (ΔT = 25.0 °C) within 5 min under MW
irradiation (Fig. 3a, b), which is enough to kill cancer cells
[40, 41]. In marked contrast, tumors showed much less
temperature change (41.3 and 40.9 °C, respectively).
Next, the in vivo therapeutic efficacy of microcapsules-








Fig. 4 Magnetic properties of chitosan/Fe3O4@ILmicrocapsules. a
The T2 relaxation rates (r2) of chitosan/Fe3O4@IL microcapsules at
different concentrations. b T2-weighted MR images of chitosan/
Fe3O4@IL. c T2-weight MR imaging of H22 tumor-bearing mice
before (left) and after (right) intratumoral injection of
chitosan/Fe3O4@IL microcapsules
Fig. 5 In vivo systematic toxicity. a Body weight curves from
healthy ICR mice injected subcutaneously in the axillary region
with 2000 mg/kg, 200 mg/kg, and without treatment. b H&E
stained images of major organs. Healthy ICR mice injected with
microcapsules were sacrificed 16 days. No noticeable
abnormality was observed in major organs including
the liver, kidney, spleen, and lung
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groups of H22 tumor-bearing mice with five mice per
group were used in our experiment. For the treatment
groups, tumors were intratumorally injected with chito-
san/Fe3O4@IL microcapsules (200 mg/kg) and then irradi-
ated by the MW at a power density of 1.8 W/cm2 for
5 min (Chitosan/Fe3O4@IL +MW). Other control groups
of mice included untreated mice (Control), mice with
chitosan/Fe3O4@ILmicrocapsule injection without MW
irradiation (Chitosan/Fe3O4@IL), and mice with MW
irradiation without chitosan/Fe3O4@IL microcapsules in-
jection (MW). The tumor sizes were measured by a
caliper every 3 days after treatment. As shown in Fig. 3c, d
and Additional file 1: Figure S4, we found that tumors
treated with chitosan/Fe3O4@ILmicrocapsules were ef-
fectively ablated after MW irradiation. However, tumor
in other control groups showed partially damaged and
exhibited a similar growth speed, suggesting that either
MW irradiation (1.8 W/cm2) or chitosan/Fe3O4@IL
microcapsule injection by itself does not affect the
tumor development (Fig. 3c, d and Additional file 1:
Figure S4). Our results demonstrate that chitosan/
Fe3O4@IL microcapsules would be a powerful MW
agent for effective tumor ablation.
MR Imaging
MR imaging can provide imaging with good anatomical
details and functional information with real-time moni-
toring manner. In consideration of that, Fe3O4-based
particles have the potential to be used as contrast agent
for T2 MR imaging. To explore the possibility of using
chitosan/Fe3O4@IL microcapsules as a T2-weighted MR
contrast agent, we measured its magnetic properties and
T2 relaxation time. The magnetic curves of the chitosan/
Fe3O4@IL microcapsules obtained at room temperature
(Additional file 1: Figure S5) showed the saturation
magnetization of 0.55 eumg−1. When placed a mag-
net, the chitosan/Fe3O4@IL microcapsules was rapidly
attracted by the magnet (inset of Additional file 1:
Figure S5). As presented in Fig. 4a b, an obvious con-
centration-dependent darkening effect in T2-weighted MR
images acquired by a 3.0 T magnetic resonance system at
room temperature was observed for chitosan/Fe3O4@IL
microcapsules. The T2 relaxivity (r2) of chitosan/
Fe3O4@IL microcapsules was measured to be 0.27943 mg
−1 mL s−1. Next in vivo experiments were used to
characterize chitosan/Fe3O4@IL microcapsules as a MR
imaging probe. Female ICR mice bearing H22 tumors
were intratumorally injected with chitosan/Fe3O4@IL
microcapsules (200 mg/kg) and imaged by a 3.0 T MR im-
aging instrument. As presented in Fig. 4c, an obviously
darkened T2 MR signals decrease of 32.27 % in the tumor
appeared, indicating that our microcapsules would be a
promising candidate as a contrast agent in MR imaging
for cancers therapy.
In Vivo Systematic Toxicity
To further study the chitosan/Fe3O4@IL microcapsules
on the toxicity of target organs, healthy ICR mice were
randomly divided into three groups (n = 5) and injected
subcutaneously in the axillary region with 2000 mg/kg,
200 mg/kg, and without treatment. Then, all mice were
sacrificed and collected their heart, liver, spleen, lung, and
kidney organs for histological examination with standard
techniques at day 16. Neither death nor significant body
weight variation was noticed after microcapsules treat-
ment during the treatment (Fig. 5a). There was no notice-
able organ damage or inflammation in these groups
(Fig. 5b). Although the systematic long-term toxicology of
chitosan/Fe3O4@IL microcapsules in animals remain to
be carefully examined, our preliminary results indicate
that chitosan/Fe3O4@IL microcapsules may not be obvi-
ously toxic to mice.
Conclusions
In summary, we have successfully fabricated a new gener-
ation of MW theranostic agent based on chitosan micro-
capsules, which could be used for MR imaging-guided
MW thermotherapy of cancer. The hemolysis rate and
HepG2 cells viability test with chitosan/Fe3O4@IL pre-
sented good biocompatibility when their concentration
were less than 2000 mg/mL and less than 1000 mg/mL,
respectively. The tumor cells were effectively ablated using
low power density (1.8 W/cm2) upon a short irradiation
time (5 min). Besides, the use of these well-prepared
chitosan/Fe3O4@IL microcapsules as MR contrast agents
was proved. Our design and the construction of chitosan/
Fe3O4@IL microcapsules could provide more opportun-
ities for further MW thermotherapy applications.
Additional File
Additional file 1: Figures S1–S5. Figure S1. Size distribution of
chitosan, chitosan/Fe3O4 and chitosan/Fe3O4@IL microcapsules were
determined by a panel of more than 200 objects in Figure 1b. Figure S2.
EDS spectrum of chitosan, chitosan/Fe3O4 and chitosan/Fe3O4@IL
microcapsules. Figure S3. TG curve of chitosan, chitosan/Fe3O4 and
chitosan/Fe3O4@IL microcapsules. Figure S4. Tumor weight in different
groups of mice after various treatments indicated. Figure S5.
Magnetization loops of chitosan/Fe3O4@IL microcapsules. Figure S6. FT-
IR spectra of IL. (DOC 259 kb)
Authors’ Contributions
HS conceived the project. HS, XM and ZH designed the research. CF and ST
created the mice model. QD prepared the nanoparticles. LT analyzed the
basic properties. TL and MN conducted the in vitro hemolysis test and MTT
assay experiments. CF, ST, QD, and LT conducted the animal experiments. ST
and TM conducted the histological study. QD conducted the CT imaging
analysis. LG conducted the CT imaging experiments of mice. ST, QD, and LT
summarized and analyzed all data. All authors provided significant revise and
have read and approved the final manuscript. The authors declare that they
have no competing interests.
Tang et al. Nanoscale Research Letters  (2016) 11:334 Page 7 of 8
Acknowledgements
The authors acknowledge the financial support from the National
Hi-Technology Research and Development Program (863 Program) (Nos.
2013AA032201 and 2012AA022701), Beijing Natural Science Foundation
(No. 4161003), the National Natural Science Foundation of China (NSFC)
(61171049, 31400854, 51202260 and 81201814), and Project of Key
Laboratory of Liaoning Province Education Department (LZ2015075).
Received: 18 May 2016 Accepted: 24 June 2016
References
1. Li X, Fan W, Zhang L, Zhao M, Huang Z, Li W, Gu Y, Gao F, Huang H, Li C,
Zhang F, Wu P (2011) CT-guided percutaneous microwave ablation of
adrenal malignant carcinoma: preliminary results. Cancer 117:5182–5188
2. Petros RA, DeSimone JM (2010) Strategies in the design of nanoparticles for
therapeutic applications. Nat Rev Drug Discov 9:615–627
3. Timmerman RD, Bizekis CS, Pass HI, Fong Y, Dupuy DE, Dawson LA, Lu D
(2009) Local surgical, ablative, and radiation treatment of metastases.
CA-Cancer J Clin 59:145–170
4. Ahmad F, Gravante G, Bhardwaj N, Strickland A, Basit R, West K, Sorge R,
Dennison AR, Lloyd DM (2010) Renal effects of microwave ablation
compared with radiofrequency, cryotherapy and surgical resection at
different volumes of the liver treated. Liver Int 30:1305–1314
5. Dooley WC, Vargas HI, Fenn AJ, Tomaselli MB, Harness JK (2010) Focused
microwave thermotherapy for preoperative treatment of invasive breast
cancer: a review of clinical studies. Ann Surg Oncol 17:1076–1093
6. Wang S, Tan L, Liang P, Liu T, Wang J, Fu C, Yu J, Dou J, Li H, Meng X
(2016) Layered MoS2 nanoflowers for microwave thermal therapy.
J Mater Chem B 4:2133–2141
7. Long D, Mao J, Liu T, Fu C, Tan L, Ren X, Shi H, Su H, Ren J, Meng X (2016)
Highly stable microwave susceptible agents via encapsulation of Ti-mineral
superfine powders in urea-formaldehyde resin microcapsules for tumor
hyperthermia therapy. Nanoscale 8:11044–11051
8. Ohlan A, Singh K, Chandra A, Dhawan SK (2010) Microwave absorption
behavior of core-shell structured poly (3,4-ethylenedioxy thiophene)-barium
ferrite nanocomposites. ACS Appl Mater Inter 2:927–933
9. Chu KF, Dupuy DE (2014) Thermal ablation of tumours: biological
mechanisms and advances in therapy. Nat Rev Cancer 14:199–208
10. Palomaki TA, Harlow JW, Teufel JD, Simmonds RW, Lehnert KW (2013)
Coherent state transfer between itinerant microwave fields and a
mechanical oscillator. Nature 495:210–214
11. Tang W, Liu B, Wang S, Liu T, Fu C, Ren X, Tan L, Duan W, Meng X (2016)
Doxorubicin-loaded ionic liquid–polydopamine nanoparticles for
combined chemotherapy and microwave thermal therapy of cancer.
RSC Adv 6:32434–32440
12. Li G, Wang L, Li W, Ding R, Xu Y (2014) CoFe2O4 and/or Co3Fe7 loaded
porous activated carbon balls as a lightweight microwave absorbent. Phys
Chem Chem Phys 16:12385–12392
13. Liu Z, Cai W, He L, Nakayama N, Chen K, Sun X, Chen X, Dai H (2007) In vivo
biodistribution and highly efficient tumour targeting of carbon nanotubes
in mice. Nat Nanotechnol 2:47–52
14. Liu T, Pang Y, Zhu M, Kobayashi S (2014) Microporous Co@CoO
nanoparticles with superior microwave absorption properties. Nanoscale
6:2447–2454
15. Tan L, Tang W, Liu T, Ren X, Fu C, Liu B, Ren J, Meng X (2016)
Biocompatible hollow polydopamine nanoparticles loaded ionic liquid
enhanced tumor microwave thermal ablation in vivo. ACS Appl Mater
Interfaces 8:11237–11245
16. Gu X, Zhu W, Jia C, Zhao R, Schmidt W, Wang Y (2011) Synthesis and
microwave absorbing properties of highly ordered mesoporous crystalline
NiFe2O4. Chem Commun 47:5337–5339
17. Patel DD, Lee JM (2012) Applications of ionic liquids. Chem Rec 12:329–355
18. Zhu Y, Wang W, Qi R, Hu X (2004) Microwave-assisted synthesis of single-
crystalline tellurium nanorods and nanowires in ionic liquids. Angewandte
Chemie 116:1434–1438
19. Wakai C, Oleinikova A, Ott M, Hermann W (2005) How polar are ionic
liquids? Determination of the static dielectric constant of an imidazolium-
based ionic liquid by microwave dielectric spectroscopy. J Phy Chem B
109(36):17028–17030
20. Deetlefs M, Seddon KR (2003) Improved preparations of ionic liquids using
microwave irradiation. Green Chem 5(2):181–186
21. Law MC, Wong KY, Chan TH (2002) Solvent-free route to ionic liquid
precursors using a water-moderated microwave process. Green Chem
4(4):328–330
22. Thomas AM, Gomez AJ, Palma JL, Yap WT, Shea LD (2014) Heparin–chitosan
nanoparticle functionalization of porous poly (ethylene glycol) hydrogels for
localized lentivirus delivery of angiogenic factors. Biomaterials 35(30):8687–8693
23. Custódio CA, Cerqueira MT, Marques AP, Reis RL, Mano JF (2015) Cell
selective chitosan microparticles as injectable cell carriers for tissue
regeneration. Biomaterials 43:23–31
24. Lim GP, Ong HY, Lee BB, Ahmad MS, Singh H, Ravindra P (2014) Effects
of process variables on size of chitosan-alginate capsules through
extrusion-dripping method. Adv Mater Res 925:8–12
25. Chen YL, Wang CY, Yang FY, Wang BS, Chen JY, Lin LT, Leu JD, Chiu SJ,
Chen FD, Lee YJ, Chen WR (2014) Synergistic effects of glycated chitosan
with high-intensity focused ultrasound on suppression of metastases in a
syngeneic breast tumor model. Cell Death Dis 5(4):e1178
26. Bhise KS, Dhumal RS, Chauhan B, Paradkar A, Kadam SS (2007) Effect of
oppositely charged polymer and dissolution medium on swelling, erosion,
and drug release from chitosan matrices. Aaps Pharmscitech 8(2):E110–E118
27. Wang L, Sun Y, Shi C, Li L, Guan J, Zhang X, Ni R, Duan X, Li Y, Mao S (2014)
Uptake, transport and peroral absorption of fatty glyceride grafted chitosan
copolymer-enoxaparin nanocomplexes: influence of glyceride chain length.
Acta Biomater 10:3675–3685
28. Guo L, Yan DD, Yang D, Li Y, Wang X, Zalewski O, Yan B, Lu W (2014)
Combinatorial photothermal and immuno cancer therapy using chitosan-coated
hollow copper sulfide nanoparticles. ACS Nano 8(6):5670–5681
29. Ahrens ET, Bulte JWM (2013) Tracking immune cells in vivo using magnetic
resonance imaging. Nat Rev Immunol 13(10):755–763
30. Lin LS, Cong ZX, Cao JB, Ke KM, Peng QL, Gao J, Yang HH, Liu G, Chen X
(2014) Multifunctional Fe3O4@ polydopamine core–shell nanocomposites
for intracellular mRNA detection and imaging-guided photothermal
therapy. ACS Nano 8(4):3876–3883
31. Li J, He Y, Sun W, Luo Y, Cai H, Pan Y, Shen M, Xia J, Shi X (2014) Hyaluronic
acid-modified hydrothermally synthesized iron oxide nanoparticles for
targeted tumor MR imaging. Biomaterials 35(11):3666–3677
32. Ammamn M, Fransaer J (2011) Synthesis and characterization of hybrid
materials based on 1-butyl-3-methylimidazolium tetrafluoroborate ionic
liquid and Dawson-type tungstophosphate K7[H4PW18O62] · H2O and
K6[P2W18O62] · 13H2O. J Solid State Chem 184:818–824
33. Smiglak M, Pringle JM, Lu X, Han L, Zhang S, Gao H, MacFarlane DR,
Rogers RD (2014) Ionic liquids for energy, materials, and medicine.
Chem Commun 50:9228–9250
34. Zhang P, Wu T, Han B (2014) Preparation of catalytic materials using ionic
liquids as the media and functional components. Adv Mater 26:6810–6827
35. Ding K, Lu H, Zhang Y, Snedaker ML, Liu D, Maciá-Agulló JA, Stucky GD
(2014) Microwave synthesis of microstructured and nanostructured metal
chalcogenides from elemental precursors in phosphonium ionic liquids.
J A Chem Soc 136(44):15465–15468
36. Scholten JD, Neto BAD, Suarez PAZ (2014) Ionic liquids as versatile
media for chemical reactions. Environmentally friendly syntheses using
ionic liquids 109.
37. Kamimura A, Murata K, Tanaka Y, Okagawa T, Matsumoto H, Kaiso K,
Yoshimoto M (2014) Rapid conversion of sorbitol to isosorbide in
hydrophobic ionic liquids under microwave irradiation. Chem Sus Chem
7(12):3257–3259
38. Barreto JA, O’Malley W, Kubeil M, Graham B, Stephan H, Spiccia L
(2011) Nanomaterials: applications in cancer imaging and therapy.
Adv Mater 23:H18–H40
39. Huang J, Xu JS, Xu RX (2010) Heat-sensitive microbubbles for intraoperative
assessment of cancer ablation margins. Biomaterials 31:1278–1286
40. Liu X, Chen HJ, Chen X, Parini C, Wen D (2012) Low frequency heating of
gold nanoparticle dispersions for non-invasive thermal therapies. Nanoscale
4:3945–3953
41. Yoon J, Cho J, Kim N, Kim DD, Lee E, Cheon C, Kwon C (2011) High-frequency
microwave ablation method for enhanced cancer treatment with minimized
collateral damage. Int J Cancer 129:1970–1978
Tang et al. Nanoscale Research Letters  (2016) 11:334 Page 8 of 8
